Evidence map›Paper›PMID 12621583›Full record

ArticleAmerican journal of human genetics2003

Refinement of a 400-kb critical region allows genotypic differentiation between isolated lissencephaly, Miller-Dieker syndrome, and other phenotypes secondary to deletions of 17p13.3.

Carlos Cardoso, Richard J Leventer, Heather L Ward, Kazuhito Toyo-Oka, June Chung, Alyssa Gross, Christa L Martin, Judith Allanson, Daniela T Pilz, Ann H Olney and 5 more

Open access · bronzeAbstract read
In one paragraph

Article in American journal of human genetics, 2003. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
7.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 281 citations in OpenAlex.

  1. Review
  2. Review
  3. Understanding the Molecular Basis of Miller-Dieker Syndrome.International journal of molecular sciences · 2025
    Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. 17p13.3 microdeletion including YWHAE and CRK genes: towards a clinical characterization.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2020
    Article
  17. Article
  18. Review
  19. Article
  20. Comprehensive genotype-phenotype correlation in lissencephaly.Quantitative imaging in medicine and surgery · 2018
    Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 7 countries.

Carlos CardosoDepartment of Human Genetics, University of Chicago, Chicago, IL 60637, USA.
Richard J Leventer
Heather L Ward
Kazuhito Toyo-Oka
June Chung
Alyssa Gross
Christa L Martin
Judith Allanson
Daniela T Pilz
Ann H Olney
Osvaldo M Mutchinick
Shinji Hirotsune
Anthony Wynshaw-Boris
William B Dobyns
David H Ledbetter
University of Chicago · USUniversity of California San Diego · USCenter for Human Genetics · USInserm · FRInstituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán · MXRoyal Children's Hospital · AUSaitama Medical University · JPUniversity Hospital of Wales · GBUniversity of Ottawa · CA

Funding

SIGNAL TRANSDUCTION PATHWAYS FOR NEURONAL MIGRATIONP01NS039404 · NINDS · UNIVERSITY OF CHICAGO · PI DOBYNS, WILLIAM B · 1999 to 2003
$4.9M
CRYPTIC TELOMERE ABNORMALITIES IN MENTAL RETARDATIONR01HD036715 · NICHD · UNIVERSITY OF CHICAGO · PI LEDBETTER, DAVID H. · 1999 to 2002
$543k
NICHD NIH HHS R01 HD36715-03NINDS NIH HHS P01 NS039404NINDS NIH HHS P01 NS39404
6 · The paper itself

Abstract

Deletions of 17p13.3, including the LIS1 gene, result in the brain malformation lissencephaly, which is characterized by reduced gyration and cortical thickening; however, the phenotype can vary from isolated lissencephaly sequence (ILS) to Miller-Dieker syndrome (MDS). At the clinical level, these two phenotypes can be differentiated by the presence of significant dysmorphic facial features and a more severe grade of lissencephaly in MDS. Previous work has suggested that children with MDS have a larger deletion than those with ILS, but the precise boundaries of the MDS critical region and causative genes other than LIS1 have never been fully determined. We have completed a physical and transcriptional map of the 17p13.3 region from LIS1 to the telomere. Using fluorescence in situ hybridization, we have mapped the deletion size in 19 children with ILS, 11 children with MDS, and 4 children with 17p13.3 deletions not involving LIS1. We show that the critical region that differentiates ILS from MDS at the molecular level can be reduced to 400 kb. Using somatic cell hybrids from selected patients, we have identified eight genes that are consistently deleted in patients classified as having MDS. In addition, deletion of the genes CRK and 14-3-3 epsilon delineates patients with the most severe lissencephaly grade. On the basis of recent functional data and the creation of a mouse model suggesting a role for 14-3-3 epsilon in cortical development, we suggest that deletion of one or both of these genes in combination with deletion of LIS1 may contribute to the more severe form of lissencephaly seen only in patients with MDS.

Indexed as

Chromosome DeletionChromosomes, Human, Pair 171-Alkyl-2-acetylglycerophosphocholine EsteraseAbnormalities, MultipleBase SequenceCongenital AbnormalitiesDNA PrimersFemaleGenotypeHumansInfantMaleMicrotubule-Associated ProteinsMolecular Sequence DataPhenotypeRetrospective Studies1-Alkyl-2-acetylglycerophosphocholine EsteraseDNA PrimersMicrotubule-Associated ProteinsPAFAH1B1 protein, humanPafah1b1 protein, mouse

Identifiers

PMID12621583
PMCPMC1180354
OpenAlexW2123607569

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.